These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18208713)

  • 1. [Prophylactic antifungal treatment in critically ill patients. A survey of a Cochrane review].
    Christensen S; Buhl M; Tønnesen EK
    Ugeskr Laeger; 2008 Jan; 170(1):36-9. PubMed ID: 18208713
    [No Abstract]   [Full Text] [Related]  

  • 2. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.
    Playford EG; Webster AC; Sorrell TC; Craig JC
    J Antimicrob Chemother; 2006 Apr; 57(4):628-38. PubMed ID: 16459344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
    Playford EG; Webster AC; Sorrell TC; Craig JC
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004920. PubMed ID: 16437504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of invasive fungal infections in immunocompromised patients with fluconazole.
    Esposito R; Uberti Foppa C; Cernuschi M
    J Chemother; 1989 Jul; 1(4 Suppl):925-6. PubMed ID: 16312707
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluconazole prophylaxis for critically ill patients at high risk for Candida infection.
    Garbino J
    Clin Infect Dis; 2005 Dec; 41(11):1690-1. PubMed ID: 16267753
    [No Abstract]   [Full Text] [Related]  

  • 6. Inadequate proof of adverse outcome due to the use of fluconazole in critically ill patients.
    Blot SI; Hoste EA; Vandewoude KH; Colardyn FA
    Arch Surg; 2000 Sep; 135(9):1114. PubMed ID: 10982521
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.
    Sohn HS; Lee TJ; Kim J; Kim D
    Clin Ther; 2009 May; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between fluconazole and ketoconazole effectivity in the treatment of pityriasis versicolor.
    Yazdanpanah MJ; Azizi H; Suizi B
    Mycoses; 2007 Jul; 50(4):311-3. PubMed ID: 17576325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy.
    Prentice AG; Glasmacher A; Djulbegovic B
    Br J Haematol; 2006 Mar; 132(5):656-8; author reply 658-9. PubMed ID: 16445845
    [No Abstract]   [Full Text] [Related]  

  • 10. What does preemptive antifungal treatment really mean?
    Stefani PM; Salvadori U; Gottardi M; Rigoli R; Scotton P; Gherlinzoni F
    Clin Infect Dis; 2010 Apr; 50(8):1201-2; author reply 1202. PubMed ID: 20233047
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hospital Universitario La Fe Guide to the prophylaxis and treatment of fungal infections in immunodepressed patients or in patients requiring special care].
    Jarque I; Salavert M; Romá E; Gobernado M; Chiveli MA; Ruano M; Solé A; Poveda JL; Ferrer E; García-Pellicer J; Sanz MA; Pemán J; Sánchez V;
    Rev Esp Quimioter; 2004 Dec; 17(4):357-89. PubMed ID: 15696227
    [No Abstract]   [Full Text] [Related]  

  • 12. Current practice of antifungal prophylaxis and treatment in immunocompromised children and adults with malignancies: a single centre approach.
    Lehrnbecher T; Mousset S; Sörensen J; Böhme A
    Mycoses; 2009 Mar; 52(2):107-17. PubMed ID: 18983431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing?
    Isaacs D
    Curr Opin Infect Dis; 2008 Jun; 21(3):246-50. PubMed ID: 18448968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation.
    Schonfeld W; Wang Cheng J; Tong KB; Seifeldin R
    Clin Ther; 2008 May; 30(5):964-73. PubMed ID: 18555943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti leishmanial therapy--the changing scene.
    Iyer SR; Iyer RR
    J Assoc Physicians India; 1995 Mar; 43(3):234. PubMed ID: 11256930
    [No Abstract]   [Full Text] [Related]  

  • 16. Prophylactic fluconazole in liver transplant recipients.
    Singh N; Yu VL
    Ann Intern Med; 2000 May; 132(10):843-4. PubMed ID: 10819716
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recommendations of antifungal treatment in patients with low grade immunosuppression].
    Barberán J; Mensa J; Fariñas C; Llinares P; Serrano R; Menéndez R; Agustí C; Gobernado M; Azanza JR; García Rodríguez JA; ; ;
    Rev Esp Quimioter; 2008 Jun; 21(2):127-42. PubMed ID: 18509772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal treatment strategies in high risk patients.
    Rüping MJ; Vehreschild JJ; Cornely OA
    Mycoses; 2008 Sep; 51 Suppl 2():46-51. PubMed ID: 18721331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective treatment for dermatophytoses of the foot: effect on restoration of depressed cell-mediated immunity.
    Schmid-Wendtner MH; Korting HC
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1013-8. PubMed ID: 17714119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of critically ill patients with candidemia.
    Mensa J; Pitart C; Marco F
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S93-7. PubMed ID: 19013347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.